Hubei Biocause Heilen Pharmaceutical Co. Ltd.

Hubei Biocause Heilen Pharmaceutical Co., Ltd. operates in the pharmaceutical, chemical, and new energy fuel businesses in China and internationally. It focuses on research, development, production, and sales of chemical raw materials and preparations, and provides contract research and development and production services. Its raw material products include non-steroidal anti-inflammatory drugs such as ibuprofen and dexibuprofen, cardiovascular drugs such as torsemide and milrinone, and anti-tumor drugs such as abiraterone acetate, fludarabine phosphate, and granisetron hydrochloride. The company also offers preparation products including torsemide tablets and ibuprofen granules. Founded in 1995, it is based in Jingmen, China.